Denali Advisors LLC Sells 22,400 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Denali Advisors LLC cut its position in USANA Health Sciences, Inc. (NYSE:USNA) by 47.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,700 shares of the company’s stock after selling 22,400 shares during the quarter. Denali Advisors LLC owned 0.13% of USANA Health Sciences worth $1,198,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Hsbc Holdings PLC bought a new position in shares of USANA Health Sciences during the third quarter worth about $570,000. Pacer Advisors Inc. increased its holdings in USANA Health Sciences by 75.7% in the fourth quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock worth $18,083,000 after purchasing an additional 145,373 shares in the last quarter. Jacobs Levy Equity Management Inc. increased its holdings in USANA Health Sciences by 2.4% in the third quarter. Jacobs Levy Equity Management Inc. now owns 90,659 shares of the company’s stock worth $5,314,000 after purchasing an additional 2,168 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of USANA Health Sciences by 3.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 677,664 shares of the company’s stock valued at $36,323,000 after buying an additional 21,524 shares during the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in shares of USANA Health Sciences by 7.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 16,534 shares of the company’s stock valued at $886,000 after buying an additional 1,162 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, DA Davidson lowered their target price on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 7th.

USANA Health Sciences Stock Up 0.1 %

Shares of NYSE:USNA traded up $0.03 during midday trading on Wednesday, reaching $44.97. 20,362 shares of the company traded hands, compared to its average volume of 80,407. USANA Health Sciences, Inc. has a 12 month low of $41.45 and a 12 month high of $69.60. The firm has a market capitalization of $856.68 million, a price-to-earnings ratio of 14.00, a price-to-earnings-growth ratio of 1.36 and a beta of 0.90. The firm’s fifty day moving average price is $46.27 and its two-hundred day moving average price is $47.88.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.17. USANA Health Sciences had a return on equity of 12.80% and a net margin of 6.88%. The company had revenue of $227.80 million for the quarter, compared to analyst estimates of $223.27 million. Analysts forecast that USANA Health Sciences, Inc. will post 2.78 earnings per share for the current year.

Insider Activity at USANA Health Sciences

In related news, major shareholder Myron W. Wentz sold 13,496 shares of the business’s stock in a transaction dated Friday, June 14th. The stock was sold at an average price of $45.03, for a total transaction of $607,724.88. Following the completion of the transaction, the insider now directly owns 7,864,345 shares in the company, valued at $354,131,455.35. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, major shareholder Myron W. Wentz sold 13,496 shares of the company’s stock in a transaction dated Friday, June 14th. The stock was sold at an average price of $45.03, for a total value of $607,724.88. Following the completion of the transaction, the insider now directly owns 7,864,345 shares in the company, valued at approximately $354,131,455.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Paul A. Jones sold 2,714 shares of the company’s stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $48.66, for a total value of $132,063.24. Following the completion of the transaction, the insider now owns 6,266 shares of the company’s stock, valued at $304,903.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 31,591 shares of company stock worth $1,458,098. 0.33% of the stock is owned by company insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.